Identity
HGNC
LOCATION
1p13.1
LOCUSID
ALIAS
CD315,CD9P-1,EWI-F,FPRP,SMAP-6
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 5738
MIM: 601204
HGNC: 9601
Ensembl: ENSG00000134247
Variants:
dbSNP: 5738
ClinVar: 5738
TCGA: ENSG00000134247
COSMIC: PTGFRN
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000134247 | ENST00000393203 | Q9P2B2 |
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 33503070 | 2021 | Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development. | 3 |
| 33503070 | 2021 | Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development. | 3 |
| 31377205 | 2019 | The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme. | 14 |
| 31377205 | 2019 | The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme. | 14 |
| 21206492 | 2011 | CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth. | 12 |
| 21206492 | 2011 | CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth. | 12 |
| 19850283 | 2010 | Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches. | 34 |
| 19850283 | 2010 | Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches. | 34 |
| 19703604 | 2009 | In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface. | 9 |
| 19703604 | 2009 | In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface. | 9 |
| 17407154 | 2007 | The transferrin receptor and the tetraspanin web molecules CD9, CD81, and CD9P-1 are differentially sorted into exosomes after TPA treatment of K562 cells. | 25 |
| 17960739 | 2007 | Glycosylation status of the membrane protein CD9P-1. | 8 |
| 17407154 | 2007 | The transferrin receptor and the tetraspanin web molecules CD9, CD81, and CD9P-1 are differentially sorted into exosomes after TPA treatment of K562 cells. | 25 |
| 17960739 | 2007 | Glycosylation status of the membrane protein CD9P-1. | 8 |
| 16537545 | 2006 | Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization. | 31 |
Citation
Dessen P
PTGFRN (prostaglandin F2 receptor inhibitor)
Atlas Genet Cytogenet Oncol Haematol. 2011-04-01
Online version: http://atlasgeneticsoncology.org/gene/52161/ptgfrn
